A
Aristeia Capital, LLC
+ HoldingIRAB
+3.11%
3M Return
$9.980
0.000 (0.00%)收盘时
Loading chart…
- High
- 9.980
- Open
- 9.980
- VWAP
- 9.98
- Vol
- 182.00
- Mkt Cap
- —
- Low
- 9.980
- Amount
- 1.82K
- EV/EBITDA, TTM
- 0.00
Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses.
AI analysis of Iris Acquisition II Corp (IRAB)
holdIris Acquisition II Corp (IRAB) is currently trading at $9.98 with a recent RSI of 66.015, indicating it is nearing overbought territory. The stock has shown a 1.11% year-to-date change, which is modest. However, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the price-to-book ratio is negative at -34.21, indicating potential valuation concerns. The main risk is the negative net income of $17,600 in Q4 2025, which raises questions about profitability. Given these factors, it is prudent to hold rather than buy at this time.
估值指标
The current forward P/E ratio for Iris Acquisition II Corp (IRAB) is 0.00, compared to its 5-year average forward P/E of .
Whales holding IRAB
事件时间线
资讯
IRAB FAQ — answered by Alphio AI
Iris Acquisition Corp II, located in Dubai, the United Arab Emirates, is a special purpose acquisition company formed for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. It operates in the Financials sector.
Iris Acquisition II Corp (IRAB) is currently trading at $9.98 with a recent RSI of 66.015, indicating it is nearing overbought territory. The stock has shown a 1.11% year-to-date change, which is modest. However, the forward P/E ratio is 0, suggesting no earnings growth expectations, and the price-to-book ratio is negative at -34.21, indicating potential valuation concerns. The main risk is the negative net income of $17,600 in Q4 2025, which raises questions about profitability. Given these factors, it is prudent to hold rather than buy at this time.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。